Orkaby, Ariela R.

Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis

Yourman, L. C., Cenzer, I. S., Boscardin, W. J., Nguyen, B. T., Smith, A. K., Schonberg, M. A., Schoenborn, N. L., Widera, E. W., Orkaby, A., Rodriguez, A., et al. (2021) · JAMA Internal Medicine

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 133

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 122

TAVR in Older Adults

Damluji, A. A., Bernacki, G., Afilalo, J., Lyubarova, R., Orkaby, A. R., Kwak, M. J., Hummel, S., Kirkpatrick, J. N., Maurer, M. S., Wenger, N., et al. (2024) · JACC: Advances

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 41